Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-10-01

Clinical Trial Update: Acute Effects of rhBNP in Patients With PH Associated With Acute Exacerbation of Chronic Pulmonary Disease [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update on acute effects of recombinant human B-type natriuretic peptide (rhBNP) in patients with pulmonary hypertension associated with a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • rhBNP (recombinant human B-type natriuretic peptide)

Snippet

Sponsor: LI ZHAO | Conditions: Pulmonary Hypertension | Phase 4 | Status: COMPLETED